Adam L Halberstadt, David E Nichols, Mark A Geyer
文献索引:Psychopharmacology 221(4) , 709-18, (2012)
全文:HTML全文
Ayahuasca is a psychoactive tea prepared from a combination of plants that contain a hallucinogenic tryptamine and monoamine oxidase inhibitors (MAOIs). Behavioral pattern monitor (BPM) experiments demonstrated that the combination of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and a behaviorally inactive dose of an MAO(A) inhibitor such as harmaline or clorgyline induces biphasic effects on locomotor activity in rats, initially reducing locomotion and then increasing activity as time progresses.The present study investigated whether the biphasic locomotor profile induced by the combination of 5-MeO-DMT and an MAOI is a consequence of a reduction in the rate of 5-MeO-DMT metabolism. This hypothesis was tested using a deuterated derivative of 5-MeO-DMT (α,α,β,β-tetradeutero-5-MeO-DMT) that is resistant to metabolism by MAO.Confirming our previous findings, 1.0 mg/kg 5-MeO-DMT (s.c.) had biphasic effects on locomotor activity in rats pretreated with a behaviorally inactive dose of the nonselective MAOI pargyline (10 mg/kg). Administration of 5-MeO-DMT alone, even at doses greater than 1.0 mg/kg, produced only reductions in locomotor activity. Although low doses of α,α,β,β-tetradeutero-5-MeO-DMT (0.3 and 1.0 mg/kg, s.c.) produced only hypoactivity in the BPM, a dose of 3.0 mg/kg induced a biphasic locomotor profile similar to that produced by the combination of 5-MeO-DMT and an MAOI. Receptor binding studies demonstrated that deuterium substitution had little effect on the affinity of 5-MeO-DMT for a wide variety of neurotransmitter binding sites.The finding with α,α,β,β-tetradeutero-5-MeO-DMT indicates that the hyperactivity induced by 5-MeO-DMT after MAO inhibition is a consequence of reduced metabolism of 5-MeO-DMT, leading to prolonged occupation of central serotonin receptors. These results demonstrate that deuterated tryptamines may be useful in behavioral and pharmacological studies to mimic the effects of tryptamine/MAOI combinations.
| 结构式 | 名称/CAS号 | 分子式 | 全部文献 |
|---|---|---|---|
![]() |
蟾蜍色胺
CAS:487-93-4 |
C12H16N2O |
|
Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, ph...
2010-10-01 [Curr. Drug Metab. 11(8) , 659-66, (2010)] |
|
Isolation of N,N-dimethyl and N-methylserotonin 5-O-β-glucos...
2010-01-01 [Biosci. Biotechnol. Biochem. 74(9) , 1951-2, (2010)] |
|
A critical review of reports of endogenous psychedelic N, N-...
2012-01-01 [Drug Test. Anal. 4(7-8) , 617-35, (2012)] |
|
Treatment of toad venom poisoning with digoxin-specific Fab ...
1996-11-01 [Chest 110(5) , 1282-8, (1996)] |
|
Sudden death associated with intravenous injection of toad e...
2009-07-01 [Forensic Sci. Int. 188(1-3) , e1-5, (2009)] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2024 ChemSrc All Rights Reserved
